Eosinophil apoptosis - Pathophysiologic and therapeutic implications

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 10, 2000, Pages 910-915

  Simon, H U ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; APOPTOSIS; CORTICOSTEROID THERAPY; EOSINOPHIL; HUMAN; IMMUNOREGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-5; LEUKOTRIENE ANTAGONISTS; PHOSPHODIESTERASE INHIBITORS;

EID: 0033810869     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.055010910.x     Document Type: Review

References (56)

1. Eosinophilia
2. Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia?
3. Death receptors: Signaling and modulation
4. A matter of life and cell death
5. Social controls on cell survival and cell death
6. Mitochondria and apoptosis
7. Caspases: Enemies within
8. Novel therapeutic strategies via the apoptosis pathways to resolve chronic eosinophilic inflammation
9. New frontiers for IL-5
10. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
11. Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic dermatitis
12. Bcl-2 expression by eosinophils in a patient with hypereosinophilia
13. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis
14. Eosinophil apoptosis in allergic diseases - An emerging new issue
15. Regulation of eosinophil apoptosis: Transduction of survival and death signals
16. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation
17. Role for Bcl-X(L) in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5
18. IL-5 but not interferon-gamma (IFN-γ) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression
19. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro
20. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways
21. Fas-mediated apoptosis in cultured human eosinophils
22. Expression and function of the Fas receptor on human blood and tissue eosinophils
23. Fas-ligand: Privilege and peril
24. Disruption of Fas receptor signaling by nitric oxide in eosinophils
25. Nitric oxide and asthmatic inflammation
26. Eosinophil apoptosis and its resolution of airway inflammation in asthma
27. Asthma
28. Expansion of cytokine-producing T cells associated with abnormal Fas expression and hypereosinophilia
29. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia
30. Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions
31. Glucocorticoids inhibit cytokine-mediated eosinophil survival
32. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes
33. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
34. Overview of effects of theophylline
35. Inhibition of natural killer cell activity by therapeutic levels of theophylline
36. Influence of cyclic nucleotides and phosphodiesterase inhibitors on in vitro human blood neutrophil chemotaxis
37. Theophylline's effect on neutrophil function and the late asthmatic response
38. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma
39. 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro
40. Agents that elevate cAMP inhibit human neutrophil apoptosis
41. Theophylline inhibits the release of eosinophil cytokines - Is Raf-I the protein kinase A target?
42. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition
43. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD1lb expression
44. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
45. Inhibitory activity of loratadine and descarboethoxyloratadine on histamine-induced activation of endothelial cells
46. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses
47. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
48. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma
49. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
50. Treatment with IFN-α in corticosteroid-unresponsive asthma
51. Interferon-α treatment of four patients with the Churg-Strauss syndrome
52. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation
53. Adoptively transferred late allergic response is inhibited by IL-4, but not IL-5, antisense oligonucleotide
54. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model
55. Interleukin-4, but not interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity
56. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation